CONVERTIBLE NOTE AMENDMENT AGREEMENTConvertible Note Amendment Agreement • June 30th, 2023 • Anzu Special Acquisition Corp I • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
Contract Type FiledJune 30th, 2023 Company Industry JurisdictionThis CONVERTIBLE NOTE AMENDMENT AGREEMENT (this “Agreement”) is entered into as of April 17, 2023, by and between Envoy Medical Corporation, a Minnesota corporation (the “Company”) and the Person listed on the signature page hereto under the heading “Note Holder” (the “Note Holder”). Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the BCA (as defined below).
ENVOY MEDICAL CORPORATION THIRD AMENDED AND RESTATED SECURED CONVERTIBLE PROMISSORY NOTESecured Convertible Promissory Note • June 30th, 2023 • Anzu Special Acquisition Corp I • Orthopedic, prosthetic & surgical appliances & supplies • Minnesota
Contract Type FiledJune 30th, 2023 Company Industry JurisdictionThis amended and restated secured convertible promissory note (“Note”) is issued to CBR HOLDINGS, LLC (“Investor”) by Envoy Medical Corporation, a Minnesota corporation (the “Company”) and replaces the second amended and restated secured convertible promissory note dated February 9, 2017, issued to Investor by the Company, whereby the Company agreed to pay Investor the principal sum of Two Hundred Thousand and No/100 Dollars ($200,000.00) (the “Previous Note”). Upon the execution of this Note, the Previous Note shall be deemed cancelled and not outstanding.
THIRD AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • June 30th, 2023 • Anzu Special Acquisition Corp I • Orthopedic, prosthetic & surgical appliances & supplies • Minnesota
Contract Type FiledJune 30th, 2023 Company Industry JurisdictionThis Third Amended and Restated Credit Agreement (this “Agreement”) is entered into between Envoy Medical Corporation, a Minnesota corporation (the “Company”), and GAT Funding, LLC, a Minnesota limited liability company (the “Investor”), effective as of July 15, 2022. The Company and Investor may be referred to herein individually as a “Party” or collectively as the “Parties.”